Publication Name	World Journal of Diabetes
Manuscript ID	8453
Country	India

Received	2013-12-28 14:52
Peer-Review Started	2013-12-28 19:31
To Make the First Decision	2014-03-26 15:18
Return for Revision	2014-03-28 14:19
Revised	2014-04-24 18:04
Second Decision	2014-05-29 16:45
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-05-29 17:04
Articles in Press	2014-05-29 17:23
Publication Fee Transferred
Edit the Manuscript by Language Editor	2014-06-13 16:00
Typeset the Manuscript	2014-08-05 18:41
Publish the Manuscript Online	2014-08-17 13:16

ISSN	1948-9358 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Review
Article Title	Targeting inflammation in diabetes: Newer therapeutic options
Manuscript Source	Invited Manuscript
All Author List	Neeraj Kumar Agrawal and Saket Kant
Funding Agency and Grant Number
Corresponding Author	Dr. Neeraj Kumar Agrawal, Associate Professor, Department of Endocrinology and Metabolism, Institiute of Medical Sciences, Banaras Hindu University, Pandit Madan Mohan Malviya Rd, Varanasi 221005, India. drnkavns@gmail.com
Key Words	Inflammation; Insulin resistance; Diabetes; Neuropathy; Retinopathy; Nephropathy
Core Tip	The burden of diabetes and its complications is increasing worldwide. To control this pandemic, drugs targeting different areas of the pathogenesis of diabetes and its complications are needed. Inflammation plays a key role in the natural history of diabetes during the progression from pre-diabetes to diabetes, including decreased beta cell secretory capacity and insulin resistance. Insulin resistance is an important part of the metabolic syndrome and plays a role in the pathogenesis of various macrovascular complications. Drugs targeting inflammatory pathways represent a fresh approach in the treatment of diabetes and its complications.
Publish Date	2014-08-17 13:16
Citation	Agrawal NK, Kant S. Targeting inflammation in diabetes: Newer therapeutic options. World J Diabetes 2014; 5(5): 697-710
URL	http://www.wjgnet.com/1948-9358/full/v5/i5/697.htm
DOI	http://dx.doi.org/10.4239/wjd.v5.i5.697

Full Article (PDF)	WJD-5-697.pdf
Full Article (Word)	WJD-5-697.doc
Manuscript File	8453-Review.docx
Answering Reviewers	8453-Answering reviewers.pdf
Copyright License Agreement	8453-Copyright assignment.pdf
Peer-review Report	8453-Peer review(s).pdf
Scientific Misconduct Check	8453-CrossCheck.jpg
Scientific Editor Work List	8453-Scientific editor work list.pdf